SCHEMBL7689877

SCHEMBL7689877

Cc1cccc(SCc2nc3cc4ccccc4cc3nc2CSc2cccc(C)c2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
DHFR P00374 1/20 0.41
LMNA P02545 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NQO2 P16083 2/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 3/20 0.37
KDM4E B2RXH2 1/20 0.37
PSMD14 O00487 1/20 0.37
CYP1A2 P05177 1/20 0.37
AGTR1 P30556 1/20 0.37
CYP2C19 P33261 1/20 0.37
OPRK1 P41145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7694096 0.84 NPC1 (0.50) SMN1; SMN2NPC1RAB9ATDP1LMNA
SCHEMBL7698454 0.83 NQO2 (0.45) SMN1; SMN2NPC1RAB9AL3MBTL1TDP1
SCHEMBL7697161 0.81 MAOA (0.43) RAB9AL3MBTL1MAOAMAOBNQO2
SCHEMBL7697050 0.81 TDP1 (0.44) L3MBTL1TDP1MAOAMAOBDHFR
SCHEMBL7699341 0.77 LMNA (0.45) SMN1; SMN2NPC1RAB9AL3MBTL1TDP1
SCHEMBL7692496 0.77 SMN1; SMN2 (0.40) SMN1; SMN2L3MBTL1TDP1LMNAMEN1
SCHEMBL7695424 0.75 CYP1A2 (0.42) NPC1RAB9ALMNAMEN1KMT2A
SCHEMBL7695589 0.75 APP (0.46) SMN1; SMN2NPC1RAB9AL3MBTL1TDP1
SCHEMBL24115709 0.75 NQO2 (0.49) SMN1; SMN2NPC1RAB9AL3MBTL1TDP1
SCHEMBL7697719 0.74 NPC1 (0.50) SMN1; SMN2NPC1RAB9AL3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed